{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T06:00:18Z","timestamp":1774677618843,"version":"3.50.1"},"reference-count":36,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"5028","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Science"],"published-print":{"date-parts":[[1991,10,4]]},"abstract":"<jats:p>The spectrum of human immunodeficiency virus type 1 (HIV-1) isolates neutralized by antibodies from HIV-1-infected humans is broader than the spectrum of isolates neutralized by sera from animals immunized with purified gp120 subunits. This broader neutralization was due, in part, to the presence of antibodies to conserved gp120 conformational epitopes. Purified conformation-dependent gp120-specific human antibodies neutralized a wider range of virus isolates than human antibodies directed to linear determinants in gp120 and were also responsible for the majority of the gp120-specific CD4-blocking activity of HIV-1-infected human sera. A gp120 subunit vaccine that effectively presents these conformation-dependent neutralization epitopes should protect against a broader range of HIV-1 variants than a vaccine that presents exclusively linear determinants.<\/jats:p>","DOI":"10.1126\/science.1718036","type":"journal-article","created":{"date-parts":[[2006,10,5]],"date-time":"2006-10-05T22:10:16Z","timestamp":1160086216000},"page":"105-108","source":"Crossref","is-referenced-by-count":180,"title":["Neutralization of Divergent HIV-1 Isolates by Conformation-Dependent Human Antibodies to Gp120"],"prefix":"10.1126","volume":"254","author":[{"given":"Kathelyn S.","family":"Steimer","sequence":"first","affiliation":[{"name":"Chiron Corporation, Emeryville, CA 94608."}]},{"given":"Carl J.","family":"Scandella","sequence":"additional","affiliation":[{"name":"Chiron Corporation, Emeryville, CA 94608."}]},{"given":"Paul V.","family":"Skiles","sequence":"additional","affiliation":[{"name":"Chiron Corporation, Emeryville, CA 94608."}]},{"given":"Nancy L.","family":"Haigwood","sequence":"additional","affiliation":[{"name":"Chiron Corporation, Emeryville, CA 94608."}]}],"member":"221","reference":[{"key":"e_1_2_1_1_1","first-page":"8583","volume":"84","year":"1987","unstructured":"ARTHUR, L.O., SEROLOGICAL RESPONSES IN CHIMPANZEES INOCULATED WITH HUMAN-IMMUNODEFICIENCY-VIRUS GLYCOPROTEIN (GP120) SUBUNIT VACCINE, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 84: 8583 (1987).","journal-title":"PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA"},{"key":"e_1_2_1_2_1","first-page":"205","volume":"43","year":"1987","unstructured":"Barr, P. J., Symposium on Molecular and Cellular Biology 43: 205 (1987).","journal-title":"Symposium on Molecular and Cellular Biology"},{"key":"e_1_2_1_3_1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0264-410X(87)90053-3","volume":"5","year":"1987","unstructured":"BARR, P.J., ANTIGENICITY AND IMMUNOGENICITY OF DOMAINS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) ENVELOPE POLYPEPTIDE EXPRESSED IN THE YEAST SACCHAROMYCES-CEREVISIAE, VACCINE 5: 90 (1987).","journal-title":"VACCINE"},{"key":"e_1_2_1_4_1","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1084\/jem.170.5.1681","volume":"170","year":"1989","unstructured":"BERKOWER, I, HUMAN IMMUNODEFICIENCY VIRUS-1 - PREDOMINANCE OF A GROUP-SPECIFIC NEUTRALIZING EPITOPE THAT PERSISTS DESPITE GENETIC-VARIATION, JOURNAL OF EXPERIMENTAL MEDICINE 170: 1681 (1989).","journal-title":"JOURNAL OF EXPERIMENTAL MEDICINE"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/345622a0"},{"key":"e_1_2_1_6_1","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1093\/nar\/19.14.3979","volume":"19","year":"1991","unstructured":"CHAPMAN, B.S., EFFECT OF INTRON-A FROM HUMAN CYTOMEGALOVIRUS (TOWNE) IMMEDIATE-EARLY GENE ON HETEROLOGOUS EXPRESSION IN MAMMALIAN-CELLS, NUCLEIC ACIDS RESEARCH 19: 3979 (1991).","journal-title":"NUCLEIC ACIDS RESEARCH"},{"key":"e_1_2_1_7_1","first-page":"2815","volume":"85","year":"1988","unstructured":"CHENGMAYER, C, IDENTIFICATION OF HUMAN IMMUNODEFICIENCY VIRUS SUBTYPES WITH DISTINCT PATTERNS OF SENSITIVITY TO SERUM NEUTRALIZATION, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 85: 2815 (1988).","journal-title":"PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA"},{"key":"e_1_2_1_8_1","doi-asserted-by":"crossref","unstructured":"Garvey J. S. Methods of Immunology 3 218 (1977).","DOI":"10.1080\/0260747770030105"},{"key":"e_1_2_1_9_1","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1097\/00002030-198901001-00017","volume":"3","year":"1989","unstructured":"GOUDSMIT, J, AIDS 3: S119 (1989).","journal-title":"AIDS"},{"key":"e_1_2_1_10_1","first-page":"31","volume":"90","year":"1990","unstructured":"HAIGWOOD, N.L., VACCINES 90: 31 (1990).","journal-title":"VACCINES"},{"key":"e_1_2_1_11_1","first-page":"51","volume":"91","year":"1991","unstructured":"HAIGWOOD, N.L., VACCINES 91: 51 (1991).","journal-title":"VACCINES"},{"key":"e_1_2_1_12_1","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1128\/jvi.61.6.2024-2028.1987","volume":"61","year":"1987","unstructured":"HO, D.D., HUMAN-IMMUNODEFICIENCY-VIRUS NEUTRALIZING ANTIBODIES RECOGNIZE SEVERAL CONSERVED DOMAINS ON THE ENVELOPE GLYCOPROTEINS, JOURNAL OF VIROLOGY 61: 2024 (1987).","journal-title":"JOURNAL OF VIROLOGY"},{"key":"e_1_2_1_13_1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1128\/jvi.65.1.489-493.1991","volume":"65","year":"1991","unstructured":"HO, D.D., CONFORMATIONAL EPITOPE ON GP120 IMPORTANT IN CD4 BINDING AND HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEUTRALIZATION IDENTIFIED BY A HUMAN MONOCLONAL-ANTIBODY, JOURNAL OF VIROLOGY 65: 489 (1991).","journal-title":"JOURNAL OF VIROLOGY"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1703322"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2392685"},{"key":"e_1_2_1_16_1","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/0092-8674(87)90524-1","volume":"50","year":"1987","unstructured":"LASKY, L.A., DELINEATION OF A REGION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 GLYCOPROTEIN CRITICAL FOR INTERACTION WITH THE CD4 RECEPTOR, CELL 50: 975 (1987).","journal-title":"CELL"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.3014647"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6206563"},{"key":"e_1_2_1_19_1","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.4049\/jimmunol.137.9.2937","volume":"137","year":"1986","unstructured":"MCDOUGAL, J.S., BINDING OF THE HUMAN RETROVIRUS HTLV-III\/LAV ARV HIV TO THE CD4 (T4) MOLECULE - CONFORMATION DEPENDENCE, EPITOPE MAPPING, ANTIBODY INHIBITION, AND POTENTIAL FOR IDIOTYPIC MIMICRY, JOURNAL OF IMMUNOLOGY 137: 2937 (1986).","journal-title":"JOURNAL OF IMMUNOLOGY"},{"key":"e_1_2_1_20_1","unstructured":"Means G. E. Chemical Modification ofProteins (1971)."},{"key":"e_1_2_1_21_1","unstructured":"Myers G. Human Retroviruses and AIDS (1990)."},{"key":"e_1_2_1_22_1","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1128\/jvi.62.8.2622-2628.1988","volume":"62","year":"1988","unstructured":"NARA, P.L., PURIFIED ENVELOPE GLYCOPROTEINS FROM HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 VARIANTS INDUCE INDIVIDUAL, TYPE-SPECIFIC NEUTRALIZING ANTIBODIES, JOURNAL OF VIROLOGY 62: 2622 (1988).","journal-title":"JOURNAL OF VIROLOGY"},{"key":"e_1_2_1_23_1","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1128\/jvi.64.8.3779-3791.1990","volume":"64","year":"1990","unstructured":"NARA, P.L., EMERGENCE OF VIRUSES RESISTANT TO NEUTRALIZATION BY V3-SPECIFIC ANTIBODIES IN EXPERIMENTAL HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-IIIB INFECTION OF CHIMPANZEES, JOURNAL OF VIROLOGY 64: 3779 (1990).","journal-title":"JOURNAL OF VIROLOGY"},{"key":"e_1_2_1_24_1","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1128\/jvi.64.12.5701-5707.1990","volume":"64","year":"1990","unstructured":"OLSHEVSKY, U, IDENTIFICATION OF INDIVIDUAL HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 AMINO-ACIDS IMPORTANT FOR CD4 RECEPTOR-BINDING, JOURNAL OF VIROLOGY 64: 5701 (1990).","journal-title":"JOURNAL OF VIROLOGY"},{"key":"e_1_2_1_25_1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/infdis\/156.2.268","volume":"156","year":"1987","unstructured":"PRINCE, A.M., PREVALENCE, CLINICAL-SIGNIFICANCE, AND STRAIN SPECIFICITY OF NEUTRALIZING ANTIBODY TO THE HUMAN-IMMUNODEFICIENCY-VIRUS, JOURNAL OF INFECTIOUS DISEASES 156: 268 (1987).","journal-title":"JOURNAL OF INFECTIOUS DISEASES"},{"key":"e_1_2_1_26_1","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.4049\/jimmunol.144.12.4641","volume":"144","year":"1990","unstructured":"PROFY, A.T., EPITOPES RECOGNIZED BY THE NEUTRALIZING ANTIBODIES OF AN HIV-1-INFECTED INDIVIDUAL, JOURNAL OF IMMUNOLOGY 144: 4641 (1990).","journal-title":"JOURNAL OF IMMUNOLOGY"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2431482"},{"key":"e_1_2_1_28_1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0264-410X(89)90164-3","volume":"7","year":"1989","unstructured":"PYLE, S.W., IMMUNE-RESPONSE TO IMMUNOSTIMULATORY COMPLEXES (ISCOMS) PREPARED FROM HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 (HIV-1) OR THE HIV-1 EXTERNAL ENVELOPE GLYCOPROTEIN (GP120), VACCINE 7: 465 (1989).","journal-title":"VACCINE"},{"key":"e_1_2_1_29_1","first-page":"7023","volume":"83","year":"1986","unstructured":"ROBEY, W.G., PROSPECT FOR PREVENTION OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTION - PURIFIED 120-KDA ENVELOPE GLYCOPROTEIN INDUCES NEUTRALIZING ANTIBODY, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 83: 7023 (1986).","journal-title":"PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.9.3198"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.3010464"},{"key":"e_1_2_1_32_1","unstructured":"SCANDELLA C.J. unpublished data."},{"key":"e_1_2_1_33_1","unstructured":"Steimer K. S. AIDS Research Reviews 2 (1992)."},{"key":"e_1_2_1_34_1","first-page":"236","volume":"87","year":"1987","unstructured":"STEIMER, K.S., VACCINES 87: 236 (1987).","journal-title":"VACCINES"},{"key":"e_1_2_1_35_1","first-page":"347","volume":"88","year":"1988","unstructured":"STEIMER, K.S., VACCINES 88: 347 (1988).","journal-title":"VACCINES"},{"key":"e_1_2_1_36_1","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/324572a0","volume":"324","year":"1986","unstructured":"WEISS, R.A., VARIABLE AND CONSERVED NEUTRALIZATION ANTIGENS OF HUMAN-IMMUNODEFICIENCY-VIRUS, NATURE 324: 572 (1986).","journal-title":"NATURE"}],"container-title":["Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/science.1718036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T14:08:11Z","timestamp":1704982091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/science.1718036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,10,4]]},"references-count":36,"journal-issue":{"issue":"5028","published-print":{"date-parts":[[1991,10,4]]}},"alternative-id":["10.1126\/science.1718036"],"URL":"https:\/\/doi.org\/10.1126\/science.1718036","relation":{},"ISSN":["0036-8075","1095-9203"],"issn-type":[{"value":"0036-8075","type":"print"},{"value":"1095-9203","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,10,4]]}}}